Finally, for individuals aged 40 to 75 years with HIV and diabetes mellitus, the panel recommends initiating moderate intensity statin therapy. Clinicians should also evaluate other risk factors that may warrant consideration of high-intensity statin therapy.1 The REPRIEVE Trial The REPRIEVE study was...
Guidelines; Diabetes mellitus; Metabolic targets; 机译:指南;糖尿病;代谢目标; 入库时间 2022-08-18 10:49:27 相似文献 外文文献 中文文献 专利 1. New guidelines for metabolic targets in diabetes: clinician's opinion does matter [J] . Katherine Esposito, Maria Ida Maiorino, Giuseppe Bellastel...
New guidelines on the treatment of cholesterol highlight four groups of people who will most likely benefit from statin therapy, and emphasize the need to tailor stain therapy to meet the individualized needs of each patient.doi:http://medicaleconomics.modernmedicine.com/node/403960M. Nierengarten...
Our analysis supports the ADA recommendations regarding a Mediterranean diet, glycemic control, and BP control, but we believe the evidence to support aspirin and statin therapy in diabetes is inconclusive. This discordance may be multi-factorial including the exclusion of some relevant studies and an...
Statins for everyone? The most effective single intervention to reduce cardiovascular risk in individuals with diabetes is lipid lowering with a statin. A retrospective study of people attending our secondary care diabetes clinic showed that... 展开 ...
Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes. Diabetes Care. 2003;26(6):1796-1801. doi:10.2337/diacare.26.6.1796 PubMedGoogle ScholarCrossref 38. Sanders GD, Neumann PJ, Basu A, et al. ...
Best practice for treating dyslipidaemia in patients with diabetes based on current international guidelines Although lifestyle modifications and statin therapy remain the cornerstone of management, add-on therapies should be strongly considered depending on the ... NSR Lan,K Burns,DA Bell,... - 《...
For patients aged 40-75 years who have diabetes but do not have ASCVD, use moderate-intensity statin treatment in addition to lifestyle therapy For patients with diabetes and ASCVD, if the low-density lipoprotein (LDL) cholesterol level is 70 mg/dL (3.9 mmol/L) or above on maximally tole...
Randomized study of evolo-cumab in patients with type 2 diabetes and dyslipidaemia on background statin:Pre-specified analysis of the Chinese population from the BERSON clinical trial[J]. Diabetes Obes Metab, 2019, 21(6):1464-1473. https://doi.org/10.1111/dom.2019.21.issue-6 https://...
Sections on drug therapy have been confined to human studies with compounds approved for clinical use in North America and/or Europe. As data on the management of patients prone to AF in special circumstances are more robust, recommendations are based on a higher level of evidence than in the...